Yongsheng Xiao Selected Research

Yongsheng Xiao Research Topics

Disease

11	Neoplasms (Cancer) 02/2024 - 12/2011
6	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 01/2019
6	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2020
3	Cholangiocarcinoma 01/2022 - 01/2021
2	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 10/2022
2	Liver Neoplasms (Liver Cancer) 01/2022 - 01/2021
2	Melanoma (Melanoma, Malignant) 01/2020 - 04/2014
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 02/2024
1	COVID-19 10/2022
1	Chest Pain (Chest Pains) 01/2021
1	Glioma (Gliomas) 01/2020
1	Endometrial Neoplasms (Endometrial Cancer) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Adenocarcinoma 01/2020
1	Infections 01/2019
1	Chemical and Drug Induced Liver Injury 01/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2017
1	Diabetes Complications 10/2016
1	Breast Neoplasms (Breast Cancer) 01/2015
1	Hypercholesterolemia 12/2011

Drug/Important Bio-Agent (IBA)

3	Phosphotransferases (Kinase)IBA 10/2016 - 04/2014
2	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2020
1	CateninsIBA 02/2024
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 12/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2023
1	Complement C5 (Complement 5)IBA 10/2022
1	Cell Adhesion MoleculesIBA 06/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 06/2022
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 06/2022
1	Chemokine ReceptorsIBA 06/2022
1	CXC ChemokinesIBA 06/2022
1	pembrolizumabIBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	NivolumabIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	camrelizumabIBA 01/2022
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2021
1	fibrin fragment D (D-dimer)IBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Histones (Histone)IBA 01/2021
1	Nucleosomes (Nucleosome)IBA 01/2021
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2020
1	ChemokinesIBA 01/2020
1	Disulfiram (Antabuse)FDA Link 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	Arginine (L-Arginine)FDA Link 01/2019
1	CopperIBA 01/2019
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2018
1	ArsenicIBA 01/2017
1	Pyruvaldehyde (Methylglyoxal)IBA 10/2016
1	Adenosine Triphosphate (ATP)IBA 01/2015
1	IsotopesIBA 01/2015
1	EnzymesIBA 04/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2011
1	Lovastatin (Mevacor)FDA LinkGeneric 12/2011

Therapy/Procedure

6	Therapeutics 02/2024 - 04/2014
3	Immunotherapy 02/2024 - 01/2021
1	Liver Transplantation 10/2022
1	Neoadjuvant Therapy 01/2022
1	Ligation 01/2020
1	Hepatectomy 01/2020
1	Radiotherapy 01/2015
1	Drug Therapy (Chemotherapy) 04/2014